Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Correction to: Investigational New Drugs https://doi.org/10.1007/s10637-022-01262-2
The figure images and its legends were missing on the online published paper.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, C., Chen, S., He, Q. et al. Correction to: A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: A case report. Invest New Drugs 40, 1357 (2022). https://doi.org/10.1007/s10637-022-01292-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-022-01292-w